Apolipoprotein M (ApoM) is a member of the apolipoprotein family, which plays a crucial role in lipid metabolism and cardiovascular health. ApoM is predominantly associated with high-density lipoproteins (HDL) and, to a lesser extent, with low-density lipoproteins (LDL) and triglyceride-rich lipoproteins . The recombinant form of ApoM, expressed in Human Embryonic Kidney (HEK) cells, has been extensively studied for its biological properties and potential therapeutic applications.
ApoM is a lipocalin protein that is secreted through the plasma membrane but remains membrane-bound, participating in lipid transport . The human recombinant ApoM produced in HEK293 cells is a single, non-glycosylated polypeptide chain containing 166 amino acids, with a molecular mass of approximately 19-24 kDa . It is expressed without a signal peptide sequence and includes a His tag at the N-terminus for purification purposes .
ApoM has several important biological functions, including:
The expression of ApoM is regulated by various factors, including:
Given its role in lipid metabolism and neuroprotection, ApoM has been investigated as a potential therapeutic target for cardiovascular diseases and neurodegenerative disorders. Its ability to bind and transport retinoic acid also highlights its importance in vitamin A metabolism and related physiological processes .